| Cardiovascular Health and Disease Prevention | Lifetime | 213 | CN 2 | 98.80 |
| Cardiovascular Disease and Adiposity | Lifetime | 226 | CN 4 | 98.72 |
| Cardiovascular Health and Risk Factors | Lifetime | 98 | CN 6 | 98.37 |
| Blood Pressure and Hypertension Studies | Lifetime | 457 | CN 3 | 98.68 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 388 | CN 6 | 98.65 |
| Heart Rate Variability and Autonomic Control | Lifetime | 650 | CN 9 | 97.97 |
| Gout, Hyperuricemia, Uric Acid | Lifetime | 210 | CN 11 | 95.57 |
| Health, Environment, Cognitive Aging | Lifetime | 427 | CN 5 | 94.55 |
| Inflammatory Biomarkers in Disease Prognosis | Lifetime | 531 | CN 82 | 91.95 |
| Cardiac Health and Mental Health | Lifetime | 987 | CN 14 | 94.45 |
| Sodium Intake and Health | Lifetime | 463 | CN 13 | 93.56 |
| Heart rate and cardiovascular health | Lifetime | 168 | CN 2 | 89.66 |
| Aortic Thrombus and Embolism | Lifetime | 812 | CN 15 | 63.35 |
| Cardiovascular Health and Disease Prevention | 2021-2025 | 1 | CN 1 | 99.84 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 3 | CN 1 | 99.64 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 10 | CN 1 | 99.71 |
| Cardiovascular Health and Risk Factors | 2021-2025 | 4 | CN 1 | 99.57 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 7 | CN 1 | 99.80 |
| Heart Rate Variability and Autonomic Control | 2021-2025 | 23 | CN 1 | 98.97 |
| Liver Disease Diagnosis and Treatment | 2021-2025 | 78 | CN 7 | 99.53 |
| Adipokines, Inflammation, and Metabolic Diseases | 2021-2025 | 19 | CN 4 | 97.57 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 104 | CN 1 | 99.25 |
| Gout, Hyperuricemia, Uric Acid | 2021-2025 | 12 | CN 1 | 97.77 |
| Health, Environment, Cognitive Aging | 2021-2025 | 37 | CN 3 | 97.25 |
| Alcohol Consumption and Health Effects | 2021-2025 | 47 | CN 5 | 97.51 |
| Inflammatory Biomarkers in Disease Prognosis | 2021-2025 | 48 | CN 22 | 95.13 |
| Inflammasome and immune disorders | 2021-2025 | 82 | CN 41 | 96.01 |
| Diet, Metabolism, and Disease | 2021-2025 | 78 | CN 7 | 97.66 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 165 | CN 48 | 94.89 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 134 | CN 4 | 96.92 |
| Sodium Intake and Health | 2021-2025 | 34 | CN 2 | 95.75 |
| Birth, Development, and Health | 2021-2025 | 344 | CN 34 | 94.75 |
| Nutritional Studies and Diet | 2021-2025 | 385 | CN 41 | 95.41 |
| Cancer Risks and Factors | 2021-2025 | 116 | CN 10 | 93.99 |
| Cardiac Health and Mental Health | 2021-2025 | 326 | CN 24 | 91.19 |
| Cerebrovascular and Carotid Artery Diseases | 2021-2025 | 732 | CN 115 | 92.55 |
| Diabetes Treatment and Management | 2021-2025 | 818 | CN 52 | 91.86 |
| Liver Disease and Transplantation | 2021-2025 | 939 | CN 64 | 91.93 |
| Health Promotion and Cardiovascular Prevention | 2021-2025 | 83 | CN 3 | 84.63 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 535 | CN 90 | 89.24 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 805 | CN 99 | 81.41 |
| Heart rate and cardiovascular health | 2021-2025 | 52 | CN 4 | 71.51 |
| Lipid metabolism and disorders | 2021-2025 | 526 | CN 133 | 70.04 |
| Case Reports on Hematomas | 2021-2025 | 384 | CN 81 | 39.02 |
